These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29667764)

  • 1. RRM2 promotes the progression of human glioblastoma.
    Li C; Zheng J; Chen S; Huang B; Li G; Feng Z; Wang J; Xu S
    J Cell Physiol; 2018 Oct; 233(10):6759-6767. PubMed ID: 29667764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase 
small subunit M2].
    Yan D; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma.
    Yang M; Yao P; Lang X; Li X; Zhang D
    Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
    Xu H; Hu Y; Qiu W
    Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
    Kang W; Tong JH; Chan AW; Zhao J; Wang S; Dong Y; Sin FM; Yeung S; Cheng AS; Yu J; To K
    Oncol Rep; 2014 Jun; 31(6):2579-86. PubMed ID: 24756820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy.
    Li J; Pang J; Liu Y; Zhang J; Zhang C; Shen G; Song L
    Oncol Rep; 2018 Jul; 40(1):355-360. PubMed ID: 29749541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
    Peng G; Liao Y; Shen C
    Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
    Das B; Jain N; Mallick B
    Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway.
    Ban Z; Li Z; Xing S; Ye Y
    PLoS One; 2024; 19(5):e0303593. PubMed ID: 38820515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRM2 is a potential prognostic biomarker with functional significance in glioma.
    Sun H; Yang B; Zhang H; Song J; Zhang Y; Xing J; Yang Z; Wei C; Xu T; Yu Z; Xu Z; Hou M; Ji M; Zhang Y
    Int J Biol Sci; 2019; 15(3):533-543. PubMed ID: 30745840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
    Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
    Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
    Zhao H; Zheng GH; Li GC; Xin L; Wang YS; Chen Y; Zheng XM
    J Cell Physiol; 2019 Dec; 234(12):23349-23359. PubMed ID: 31169309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β‑catenin signaling pathway.
    Liu X; Peng J; Zhou Y; Xie B; Wang J
    Mol Med Rep; 2019 Sep; 20(3):2159-2166. PubMed ID: 31322175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
    Fang Z; Gong C; Liu H; Zhang X; Mei L; Song M; Qiu L; Luo S; Zhu Z; Zhang R; Gu H; Chen X
    Biochem Biophys Res Commun; 2015 Aug; 464(2):407-15. PubMed ID: 26093293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
    Zhang M; Wang J; Yao R; Wang L
    Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
    Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
    Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
    Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
    Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma.
    Chen L; Wang L; Qin J; Wei DS
    Life Sci; 2020 Dec; 262():118477. PubMed ID: 32971103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.